Literature DB >> 6821904

Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.

C Richard, J L Ricome, A Rimailho, G Bottineau, P Auzepy.   

Abstract

In eight mechanically ventilated patients in cardiogenic shock, we assessed the hemodynamic effects of an infusion of dopamine and dobutamine and evaluated its role in preventing the deleterious effects of administering each amine alone. Each patient received three infusions in a randomly assigned order: dopamine, 15 micrograms/kg/min; dobutamine, 15 micrograms/kg/min; and a combination of dopamine, 7.5 micrograms/kg/min, and dobutamine, 7.5 micrograms/kg/min. Stroke volume index increased similarly with the three infusions, but dopamine alone increased oxygen consumption (p less than 0.05 vs dobutamine alone and dopamine-dobutamine combined). The dopamine-dobutamine combination increased mean arterial pressure (p less than 0.05 vs dobutamine), maintained pulmonary capillary wedge pressure within normal limits (p less than vs dopamine), and prevented the worsening of hypoxemia induced by dopamine (p less than 0.05). The dopamine-dobutamine combination appears to be useful in the management of mechanically ventilated patients in cardiogenic shock.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6821904     DOI: 10.1161/01.cir.67.3.620

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Cardiogenic shock. Current concepts in management.

Authors:  K Balakumaran; P G Hugenholtz
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

2.  A heart transplant candidate with severe pulmonary hypertension and extremely high pulmonary vascular resistance.

Authors:  Takuma Sato; Osamu Seguchi; Nagisa Morikawa; Michinari Hieda; Takuya Watanabe; Haruki Sunami; Yoshihiro Murata; Masanobu Yanase; Hiroki Hata; Tomoyuki Fujita; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2013-02-27       Impact factor: 1.731

Review 3.  Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.

Authors:  Julia Schumann; Eva C Henrich; Hellen Strobl; Roland Prondzinsky; Sophie Weiche; Holger Thiele; Karl Werdan; Stefan Frantz; Susanne Unverzagt
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29

Review 4.  Catecholamines in critical care. The commonly used catecholamines: receptor and clinical profile, indications and dosages.

Authors:  F W Santman
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

Review 5.  Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.

Authors:  A Fitton; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.

Authors:  B E Jaski; W Wijns; R Foulds; P W Serruys
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

7.  Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.

Authors:  Rasha Kaddoura; Amr Elmoheen; Ehab Badawy; Mahmoud F Eltawagny; Mohamed A Seif; Khalid Bashir; Amar M Salam
Journal:  J Drug Assess       Date:  2021-07-20

8.  Experts' recommendations for the management of adult patients with cardiogenic shock.

Authors:  Bruno Levy; Olivier Bastien; Bendjelid Karim; Karim Benjelid; Alain Cariou; Tahar Chouihed; Alain Combes; Alexandre Mebazaa; Bruno Megarbane; Patrick Plaisance; Alexandre Ouattara; Christian Spaulding; Christian Splaulding; Jean-Louis Teboul; Fabrice Vanhuyse; Thierry Boulain; Kaldoun Kuteifan
Journal:  Ann Intensive Care       Date:  2015-07-01       Impact factor: 6.925

Review 9.  Shock - Classification and Pathophysiological Principles of Therapeutics.

Authors:  Olga N Kislitsina; Jonathan D Rich; Jane E Wilcox; Duc T Pham; Andrei Churyla; Esther B Vorovich; Kambiz Ghafourian; Clyde W Yancy
Journal:  Curr Cardiol Rev       Date:  2019

10.  A review of cardiogenic shock in acute myocardial infarction.

Authors:  L Khalid; S H Dhakam
Journal:  Curr Cardiol Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.